findmyKOL

Glenn Mathisen, MD

Basic profile

Olive View-UCLA Medical Center

ORCIDNone on fileNPI
RegionLos Angeles, CA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Glenn Mathisen is an Infectious Disease physician affiliated with Olive View-UCLA Medical Center. OpenAlex indexes 60 publications with 2,342 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
60publications

Distinct works indexed by OpenAlex.

2,342citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    40.8%
    Calcium channel blocker11.6%
    Amlodipine Besylate100%
    Part D<11 patients
    Statin11.6%
    Atorvastatin Calcium100%
    Part D<11 patients

    + 2 more classes in this area

  • Anti-infectives

    27.9%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor17%
    Triumeq100%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor10.9%
    Juluca100%
    Part D<11 patients
  • Genitourinary & hormones

    15%
    Cholinergic Muscarinic Antagonist7.5%
    Oxybutynin Chloride100%
    Part D<11 patients
    alpha-Adrenergic Blocker7.5%
    Tamsulosin Hcl100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”